Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Tembuyser, L."'
Autor:
Keppens , C., Tack , V., 't Hart , N., Tembuyser , L., Ryska , A., Pauwels , P., Zwaenepoel , K., Schuuring , E., Cabillic , F., Tornillo , L., Warth , A., Weichert , W., Dequeker , E., Lukas , B., Sofie , D., Keith , M., Erik , T.
Publikováno v:
Oncotarget
Oncotarget, 2018, 9 (29), pp.20524-20538. 〈10.18632/oncotarget.24980〉
Oncotarget, 2018, 9 (29), pp.20524-20538. 〈10.18632/oncotarget.24980〉
International audience; Biomarker analysis has become routine practice in the treatment of non-small cell lung cancer (NSCLC). To ensure high quality testing, participation to external quality assessment (EQA) schemes is essential. This article provi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::30262404094401bd0f670e4e04794c0e
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01809328
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01809328
Autor:
Tembuyser, L., Ligtenberg, M.J.L., Normanno, N., Delen, S., Krieken, J.H.J.M. van, Dequeker, E.M.
Publikováno v:
Journal of Molecular Diagnostics, 16, 3, pp. 371-7
Journal of Molecular Diagnostics, 16, 371-7
Journal of Molecular Diagnostics, 16, 371-7
Contains fulltext : 138176.pdf (Publisher’s version ) (Closed access) Precision medicine is now a key element in clinical oncology. RAS mutational status is a crucial predictor of responsiveness to anti-epidermal growth factor receptor agents in me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::785d36f2c90bb829e98b6eab05e9645d
https://hdl.handle.net/2066/138176
https://hdl.handle.net/2066/138176
Autor:
Keppens C; University of Leuven, Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, Leuven, Belgium., Tack V; University of Leuven, Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, Leuven, Belgium., Hart N'; University Medical Center Groningen, Department of Pathology, Groningen, The Netherlands., Tembuyser L; University of Leuven, Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, Leuven, Belgium., Ryska A; Charles University Medical Faculty and University Hospital, Department of Pathology, Hradec Kralove, Czech Republic., Pauwels P; Center for Oncologic Research (CORE), University of Antwerp, Antwerp, Belgium., Zwaenepoel K; University Hospital Antwerp, Department of Pathology, Edegem, Belgium., Schuuring E; University Medical Center Groningen, Department of Pathology, Groningen, The Netherlands., Cabillic F; Cytogenetics and Cellular Biology Department, CHU de Rennes, Rennes, France.; INSERM, INRA, Université Rennes 1, Université Bretagne Loire, Nutrition Metabolisms and Cancer, Rennes, France., Tornillo L; University of Basel, Basel, Switzerland.; GILAB AG, Allschwil, Switzerland., Warth A; University Hospital Heidelberg, Heidelberg, Germany., Weichert W; Technical University Munich (TUM), Munich, Germany., Dequeker E; University of Leuven, Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, Leuven, Belgium.
Publikováno v:
Oncotarget [Oncotarget] 2018 Apr 17; Vol. 9 (29), pp. 20524-20538. Date of Electronic Publication: 2018 Apr 17 (Print Publication: 2018).
Publikováno v:
In Annals of Oncology September 2014 25 Supplement 4:iv48-iv48
Publikováno v:
Biomolecules (2218-273X). Feb2024, Vol. 14 Issue 2, p168. 13p.
Autor:
Boleij A; Department of Pathology, Radboud University Medical Centre, Geert Grooteplein-Zuid 10, 6525 GA, Nijmegen, The Netherlands., Tack V; Department of Public Health and Primary Care, University of Leuven, Herestraat 49, Box 602, 3000, Leuven, Belgium., Taylor A; Centre for Observational Research, Amgen Ltd, 1 Uxbridge Business Park, Uxbridge, UB8 1DH, UK., Kafatos G; Centre for Observational Research, Amgen Ltd, 1 Uxbridge Business Park, Uxbridge, UB8 1DH, UK., Jenkins-Anderson S; Adelphi Research (Global), Adelphi Mill, Bollington, Manchester, SK10 5JB, UK., Tembuyser L; Department of Public Health and Primary Care, University of Leuven, Herestraat 49, Box 602, 3000, Leuven, Belgium., Dequeker E; Department of Public Health and Primary Care, University of Leuven, Herestraat 49, Box 602, 3000, Leuven, Belgium. Els.dequeker@kuleuven.be., van Krieken JH; Department of Pathology, Radboud University Medical Centre, Geert Grooteplein-Zuid 10, 6525 GA, Nijmegen, The Netherlands.
Publikováno v:
BMC cancer [BMC Cancer] 2016 Oct 26; Vol. 16 (1), pp. 825. Date of Electronic Publication: 2016 Oct 26.
Autor:
Tembuyser L; Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, KU Leuven - University of Leuven, Herestraat 49, box 602, 3000, Leuven, Belgium., Dequeker EM; Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, KU Leuven - University of Leuven, Herestraat 49, box 602, 3000, Leuven, Belgium. els.dequeker@med.kuleuven.be.
Publikováno v:
Virchows Archiv : an international journal of pathology [Virchows Arch] 2016 Jan; Vol. 468 (1), pp. 31-41. Date of Electronic Publication: 2015 Aug 26.
Autor:
Tack V; Biomedical Quality Assurance Research Unit, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands; Cell Biology and Biotherapy Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione Giovanni Pascale' - IRCCS, Naples, Italy; Department of Pathology, UZ Leuven, Leuven, Belgium., Ligtenberg MJ; Biomedical Quality Assurance Research Unit, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands; Cell Biology and Biotherapy Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione Giovanni Pascale' - IRCCS, Naples, Italy; Department of Pathology, UZ Leuven, Leuven, Belgium., Tembuyser L; Biomedical Quality Assurance Research Unit, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands; Cell Biology and Biotherapy Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione Giovanni Pascale' - IRCCS, Naples, Italy; Department of Pathology, UZ Leuven, Leuven, Belgium., Normanno N; Biomedical Quality Assurance Research Unit, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands; Cell Biology and Biotherapy Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione Giovanni Pascale' - IRCCS, Naples, Italy; Department of Pathology, UZ Leuven, Leuven, Belgium., Vander Borght S; Biomedical Quality Assurance Research Unit, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands; Cell Biology and Biotherapy Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione Giovanni Pascale' - IRCCS, Naples, Italy; Department of Pathology, UZ Leuven, Leuven, Belgium., Han van Krieken J; Biomedical Quality Assurance Research Unit, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands; Cell Biology and Biotherapy Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione Giovanni Pascale' - IRCCS, Naples, Italy; Department of Pathology, UZ Leuven, Leuven, Belgium., Dequeker EM; Biomedical Quality Assurance Research Unit, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands; Cell Biology and Biotherapy Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione Giovanni Pascale' - IRCCS, Naples, Italy; Department of Pathology, UZ Leuven, Leuven, Belgium els.dequeker@med.kuleuven.be.
Publikováno v:
The oncologist [Oncologist] 2015 Mar; Vol. 20 (3), pp. 257-62. Date of Electronic Publication: 2015 Feb 05.
Autor:
Potocki, Paweł Michał1 (AUTHOR) pawel.potocki@uj.edu.pl, Wiśniowski, Rafał2 (AUTHOR), Haus, Dominik3 (AUTHOR), Chowaniec, Zbyszko4 (AUTHOR), Kozaczka, Maciej5 (AUTHOR), Kustra, Magdalena5 (AUTHOR), Samborska-Plewicka, Marzenna5 (AUTHOR), Szweda, Marcin5 (AUTHOR), Starzyczny-Słota, Danuta6 (AUTHOR), Michalik, Magdalena7 (AUTHOR), Słomian, Grzegorz7 (AUTHOR), Lebiedzińska, Aneta8,9 (AUTHOR), Jonak-Olczyk, Natalia10 (AUTHOR), Łaszewska-Kraińska, Natalia11 (AUTHOR), Adamowicz, Krzysztof12 (AUTHOR), Kolenda, Piotr13 (AUTHOR), Drosik-Kwaśniewska, Anna14 (AUTHOR), Szwiec, Marek15 (AUTHOR), Dziura, Robert16 (AUTHOR), Czech, Justyna17 (AUTHOR)
Publikováno v:
Cancers. Sep2023, Vol. 15 Issue 17, p4361. 17p.
Autor:
Tembuyser L; Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, KU Leuven - University of Leuven, Leuven, Belgium., Tack V; Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, KU Leuven - University of Leuven, Leuven, Belgium., Zwaenepoel K; Department of Pathology, Antwerp University Hospital, Edegem, Belgium., Pauwels P; Department of Pathology, Antwerp University Hospital, Edegem, Belgium., Miller K; UK NEQAS ICC & ISH, London, United Kingdom., Bubendorf L; Institute for Pathology, Basel University Hospital, Basel, Switzerland., Kerr K; Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom., Schuuring E; Department of Pathology and Medical Biology, University of Groningen, Groningen, the Netherlands., Thunnissen E; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Dequeker EM; Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, KU Leuven - University of Leuven, Leuven, Belgium.
Publikováno v:
PloS one [PLoS One] 2014 Nov 11; Vol. 9 (11), pp. e112159. Date of Electronic Publication: 2014 Nov 11 (Print Publication: 2014).